Navigo Proteins GmbH
- Biotech or pharma, therapeutic R&D
Navigo is a German near-clinical biotech developing innovative next-generation targeted radiotherapies based on cutting-edge, proprietary target binding protein platform called Affilins®. Several ready-to-partner radiotherapeutic assets available.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}